Hexestrol diphosphate
Clinical data
Trade namesCytostatin, Cytostesin, Pharmestrin, Retalon Aquosum
Other namesDA-268; NSC-35752
Routes of
administration		Intravenous injection
Drug classEstrogen; Nonsteroidal estrogen
Identifiers
  • [4-[(3S,4R)-4-(4-phosphonooxyphenyl)hexan-3-yl]phenyl] dihydrogen phosphate
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC18H24O8P2
Molar mass430.330 g·mol−1
3D model (JSmol)
  • CCC(C1=CC=C(C=C1)OP(=O)(O)O)C(CC)C2=CC=C(C=C2)OP(=O)(O)O
  • InChI=1S/C18H24O8P2/c1-3-17(13-5-9-15(10-6-13)25-27(19,20)21)18(4-2)14-7-11-16(12-8-14)26-28(22,23)24/h5-12,17-18H,3-4H2,1-2H3,(H2,19,20,21)(H2,22,23,24)/t17-,18+
  • Key:JBDIWCWZUDNWTL-HDICACEKSA-N

Hexestrol diphosphate (brand names Cytostatin, Cytostesin, Pharmestrin, Retalon Aquosum) is a synthetic, nonsteroidal estrogen of the stilbestrol group related to diethylstilbestrol and used as an estrogen and antineoplastic agent in the treatment of prostate cancer.[1][2][3] It is a water-soluble ester of hexestrol.[1] The medication has been known since at least 1956.[3]

See also

References

  1. 1 2 Elks J (14 November 2014). "Chemical Data, Structures and Bibliographies". In Ganellin J, Elks J (eds.). The Dictionary of Drugs. Springer. p. 163. doi:10.1007/978-1-4757-2085-3. ISBN 978-1-4757-2085-3. OCLC 898564124.
  2. ↑ Milne GW (8 May 2018). Drugs: Synonyms and Properties: Synonyms and Properties. Taylor & Francis. pp. 1408–. ISBN 978-1-351-78989-9.
  3. 1 2 Adami E, Marazzi-Uberti E (July–December 1956). "[Experimental research on prostatic antineoplastic agent: hexestrol diphosphate]". Giornale Italiano di Chemioterapia (in Italian). 3 (3–4): 362–9. ISSN 0017-0445. PMID 13462184.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.